XBIT Stock Analysis: Buy, Sell, or Hold?
XBIT - XBiotech Inc
$2.32
-0.02 (-0.85%)
▼
5d:
-2.11%
30d:
-3.33%
90d:
-1.69%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 12, 2026
Get Alerted When XBIT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XBIT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XBIT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XBIT is currently trading at $2.32, which is considered oversold relative to its 30-day fair value range of $2.33 to $2.42.
Technical Outlook: Technically, XBIT is showing sideways momentum. The price is currently testing key support at $2.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XBIT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.00 (+669.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XBIT is showing sideways momentum. The price is currently testing key support at $2.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: XBIT has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $18.00 (+669.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.33 -
$2.42
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 669.2% below Wall St target ($18.00)
Trading Range Analysis
30-Day Trading Range
$2.33 -
$2.42
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.34
Resistance Level
$2.48
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$18.00
(+669.2%)
Revenue Growth (YoY)
-93.3%
Share & Embed Analysis
Last updated: June 25, 2026 12:30 PM ET
Data refreshes hourly during market hours. Next update: 1:30 PM
Data refreshes hourly during market hours. Next update: 1:30 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 57 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 58 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |
|
RYTM
Rhythm Pharmaceuticals I… |
STRONG BUY
12 analysts |
$139 | 63 BUY |
